Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Mediastinal staging (take home messages).

Bernward Passlick1

  • 1Dept. of Thoracic Surgery, University Hospital Freiburg, Hugstetter Strasse 55, D-79106 Freiburg, Germany. passlick@ch11.ukl.uni-freiburg.de

Lung Cancer (Amsterdam, Netherlands)
|November 24, 2004
PubMed
Summary

Accurate staging of non-small cell lung cancer (NSCLC) relies on mediastinal lymph node assessment. While cervical mediastinoscopy is standard, FDG PET scans improve metastasis detection, guiding further invasive examination for precise N staging.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zentralblatt fur Chirurgie·2025
Same author

Detection of malignant lung tumors using stimulated Raman histology and convolutional neural networks.

Journal of thoracic disease·2025
Same author

SARS-CoV-2 infection dynamics in a MHCI-mismatched lung transplant recipient.

Nature communications·2025
Same author

Implications of modernized chest tube management after anatomic lung resection as an aspect of enhanced recovery after surgery (ERAS).

Journal of thoracic disease·2025
Same author

Influence of preprocessing of stimulated Raman scattering images on the performance of deep neural networks for detecting cancer tissue.

Quantitative imaging in medicine and surgery·2025
Same author

The Ectonucleotidases CD39 and CD73 and the Purinergic Receptor P2X4 Serve as Prognostic Markers in Non-Small Cell Lung Cancer.

Cancers·2025

Area of Science:

  • Oncology
  • Medical Imaging
  • Thoracic Surgery

Background:

  • Mediastinal lymph node involvement is a critical prognostic factor in non-small cell lung cancer (NSCLC).
  • Cervical mediastinoscopy is the current gold standard for mediastinal lymph node staging.
  • Less invasive techniques like transbronchial and transoesophageal fine-needle aspiration (FNA) are emerging alternatives.

Purpose of the Study:

  • To evaluate the role of imaging and pathological analysis in mediastinal lymph node staging for NSCLC.
  • To compare the accuracy of FDG PET and CT in detecting mediastinal lymph node metastases.
  • To assess the utility of FDG PET in identifying distant metastases and guiding invasive staging procedures.

Main Methods:

  • Review of current literature on mediastinal lymph node staging in NSCLC.

Related Experiment Videos

  • Comparison of diagnostic accuracy between FDG PET, CT, and invasive methods (mediastinoscopy, FNA).
  • Emphasis on the importance of pathological analysis for accurate N staging.

    • Main Results:

    • FDG PET demonstrates higher accuracy than CT in detecting mediastinal lymph node metastases.
    • Positive FDG PET findings necessitate invasive confirmation, often via mediastinoscopy.
    • FDG PET may aid in detecting asymptomatic distant metastases.
    • Pathological analysis is crucial for definitive N stage determination.

    Conclusions:

    • FDG PET enhances the detection of mediastinal lymph node metastases in NSCLC, complementing CT.
    • While FDG PET guides invasive staging, pathological examination remains essential for accurate N staging.
    • Emerging less invasive FNA techniques may supplement or, in specific cases, replace mediastinoscopy.